Skip to main content

Table 2 Comparison of 1229 patients’ clinical characteristics in two groups

From: The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia

Characteristics

Total

High (n=614)

Low (n=615)

P

Age group/n (%)

   

< 0.001§

 < 60 years

750 (61.0)

308 (50.2)

442 (71.9)

 

 ≥ 60 years

428 (34.8)

276 (44.9)

152 (24.7)

 

 NA

51 (4.2)

30 (4.9)

21 (3.4)

 

WBC/n (%)

   

0.798§

 < 10 %

29 (2.4)

12 (2.0)

17 (2.8)

 

 ≥ 10 %

62 (5.0)

29 (4.7)

33 (5.3)

 

 NA

1138 (92.6)

573 (93.3)

565 (91.9)

 

PB blasts/n (%)

   

0.635§

 < 40 %

48 (3.9)

20 (3.3)

28 (4.5)

 

 ≥40 %

43 (3.5)

21 (3.4)

22 (3.6)

 

 NA

1138 (92.6)

573 (93.3)

565 (91.9)

 

BM blasts /n (%)

   

0.462§

 < 50 %

18 (1.5)

10 (1.6)

8 (1.3)

 

 ≥ 50 %

73 (5.9)

31 (5.1)

42 (6.8)

 

 NA

1138 (92.6)

573 (93.3)

565 (91.9)

 

Risk/n (%)

   

< 0.001§

 Good

55 (4.5)

9 (1.5)

46 (7.5)

 

 Intermediate

175 (14.2)

67 (10.9)

108 (17.6)

 

 Poor

53 (4.3)

32 (5.2)

21 (3.4)

 

 NA

946 (77.0)

506 (82.4)

440 (71.5)

 

OS/n (%)

   

< 0.001§

 Alive

413 (33.6)

78 (12.7)

335 (54.5)

 

 Dead

816 (66.4)

536 (87.3)

280 (45.5)

 
  1. Abbreviations: WBC, white blood cell; BM, bone marrow; PB, peripheral blood; NA, not applicable
  2. §Chi-square test